Hepatobiliary & pancreatic diseases international
ISSN 1499-3872 · Elsevier BV · Singapore · active 2010–2026
Metrics
- Best Scimago quartile (2025)
- Q1
- Cites per paper (2y)
- 1.5
- SJR
- 1.021
- h-index
- 56
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.
Data as of 8 November 2026 (venue index build).
Scimago Journal Rank 2025
In the Scimago Journal Rank 2025 edition, Hepatobiliary & pancreatic diseases international is Q1 in 1 of its 2 subject categories and Q2 in the other 1. Its best category quartile is Q1.
| Subject category | Quartile | Rank in category |
|---|---|---|
| Gastroenterology | Q1 | #41 of 178 |
| Hepatology | Q2 | #31 of 90 |
- Cites per document (2 years, Scopus)
- 2.37
- Documents indexed in 2025 (Scopus)
- 134
OpenAlex counts about 1.5 citations per paper over two years; Scopus, through Scimago, counts 2.37 per document. The two databases index different journals, documents and citations, so the figures differ. Neither is a Clarivate Journal Impact Factor.
The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).
Hepatobiliary & pancreatic diseases international is Q1 in 1 of its 2 Scimago subject categories (2025 edition; best category Gastroenterology: Q1, #41 of 178), with SJR 1.021 (Scimago) and an h-index of 56 (OpenAlex). Listed in Scopus, Web of Science, PubMed.
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Indexing & access
- Indexed in
- ScopusWeb of SciencePubMed
- Access status:
- subscription. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Hepatobiliary & pancreatic diseases international a predatory journal?
Our screening does not flag Hepatobiliary & pancreatic diseases international. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Hepatobiliary & pancreatic diseases international indexed in Scopus or Web of Science?
Per our venue index, Hepatobiliary & pancreatic diseases international appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of Hepatobiliary & pancreatic diseases international?
Papers in Hepatobiliary & pancreatic diseases international are cited about 1.5 times each within two years of publication, and Scimago places it in Q1, with an h-index of 56. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
What Scimago quartile is Hepatobiliary & pancreatic diseases international (Q1, Q2, Q3, or Q4)?
In the Scimago Journal Rank 2025 edition, Hepatobiliary & pancreatic diseases international is Q1 in 1 of its 2 subject categories and Q2 in the other 1. By category: Gastroenterology: Q1, #41 of 178; Hepatology: Q2, #31 of 90. Its best category quartile is Q1. Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Hepatobiliary & pancreatic diseases international is cited about 1.5 times per paper over two years, with an h-index of 56.
What is the Web of Science (JCR) quartile of Hepatobiliary & pancreatic diseases international?
The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Hepatobiliary & pancreatic diseases international. The open equivalent is its best Scimago quartile, Q1 in Gastroenterology, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.
Is Hepatobiliary & pancreatic diseases international open access?
Our index records its access status as "subscription". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
Ready to submit? Tools for your next paper
Similar venues
- Surgical Clinics of North AmericaQ1 · Elsevier BV
- Medical ArchivesQ3 · Academy of Medical Sciences of Bosnia and Herzegovina
- The Turkish Journal of GastroenterologyQ3
- JPRAS OpenQ2 · Elsevier BV
- Acta Orthopaedica et Traumatologica TurcicaQ2 · Elsevier BV
- Anaesthesia & intensive care medicineQ3 · Elsevier BV
Compare it with its peers: Ranked Surgery journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.